- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Pharmaceutical Care to a Patient with Dysphagia Who Needs Gefitinib Chemotherapy
-
- MASE Satoru
- Pharmaceutical and Feeding Dept. Anjo-kosei Hospital
-
- YONEYAMA Eiji
- Pharmaceutical and Feeding Dept. Anjo-kosei Hospital
-
- NEGITA Kazumasa
- Pharmaceutical and Feeding Dept. Anjo-kosei Hospital
-
- SUGIURA Yoji
- Pharmaceutical and Feeding Dept. Anjo-kosei Hospital
-
- MIURA Takanori
- Pharmaceutical and Feeding Dept. Anjo-kosei Hospital
-
- KATSUMI Akio
- Pharmaceutical and Feeding Dept. Anjo-kosei Hospital
-
- HARA Toru
- Dept. of Respiratory Medicine, Anjo-kosei Hospital
Bibliographic Information
- Other Title
-
- 内服困難な患者に対するゲフィチニブ投与に薬剤師が効果的に介入できた1例
- 症例報告 内服困難な患者に対するゲフィチニブ投与に薬剤師が効果的に介入できた1例
- ショウレイ ホウコク ナイフク コンナンナ カンジャ ニ タイスル ゲフィチニブ トウヨ ニ ヤクザイシ ガ コウカテキ ニ カイニュウ デキタ 1レイ
Search this article
Description
Recently, in order to make chemotherapy, safer and more effective various forms of intervention by pharmacists are needed. In this paper, we report our experience in intervening in the administration of gefitinib to a patient with dysphagia. Chemotherapy with an intravenous drip injection to the 58 year-old woman admitted to our hospital for non-small cell lung cancer (NSCLC) was withdrawn due to severe pancytopenia after the first cycle of pharamcotherapy. Then, as an altermative, oral medication, of gefitinib was suggested by medical doctors. However, the oral administration was inappropriate to the condition of the patient. She was unable to keep taking gefitinib pills because she had been suffering from a progressive swallowing disturbance due to progressive non-small cell lung cancer. Thus, we proposed another oral administration method in which gefitinib was resuspended in thickening agents. This method made it possible for the patient to take gefitinib without any adverse events until the day before the patient died.
Journal
-
- JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE
-
JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE 57 (1), 28-33, 2008
THE JAPANESE ASSOCIATION OF RURAL MEDICINE
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679886653184
-
- NII Article ID
- 130004451156
- 10024163091
-
- NII Book ID
- AN00196216
-
- ISSN
- 13497421
- 04682513
-
- NDL BIB ID
- 9543085
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed